Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902219-11-000001
Filing Date
2011-01-10
Accepted
2011-01-10 14:05:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC FILING sec_filing.htm SC 13G/A 17766
  Complete submission text file 0000902219-11-000001.txt   19793
Mailing Address 75 STATE STREET BOSTON MA 02109
Business Address 75 STATE STREET BOSTON MA 02109 6179515000
WELLINGTON MANAGEMENT CO LLP (Filed by) CIK: 0000902219 (see all company filings)

EIN.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7
Business Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7 416-260-7770
Transition Therapeutics Inc. (Subject) CIK: 0001399250 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-83093 | Film No.: 11519767
SIC: 2833 Medicinal Chemicals & Botanical Products